CAPTRUST Financial Advisors
NVO

CAPTRUST Financial Advisors’s Novo Nordisk NVO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.25M Buy
143,005
+23,442
+20% +$1.11M 0.01% 746
2025
Q4 		$6.08M Sell
119,563
-31,782
-21% -$1.63M 0.01% 615
2025
Q3 		$8.4M Sell
151,345
-9,296
-6% -$544K 0.02% 515
2025
Q2 		$11.1M Sell
160,641
-28,101
-15% -$1.91M 0.02% 440
2025
Q1 		$13.1M Buy
188,742
+52,156
+38% +$4.31M 0.03% 366
2024
Q4 		$11.7M Sell
136,586
-18,626
-12% -$2.01M 0.03% 337
2024
Q3 		$18.5M Sell
155,212
-5,611
-3% -$748K 0.05% 256
2024
Q2 		$23M Buy
160,823
+10,997
+7% +$1.46M 0.07% 197
2024
Q1 		$19.2M Buy
149,826
+4,947
+3% +$589K 0.07% 228
2023
Q4 		$15M Buy
144,879
+34,278
+31% +$3.39M 0.05% 286
2023
Q3 		$10.1M Buy
110,601
+28,361
+34% +$2.5M 0.04% 337
2023
Q2 		$6.65M Buy
82,240
+2,564
+3% +$209K 0.03% 416
2023
Q1 		$6.34M Buy
79,676
+8,740
+12% +$620K 0.03% 402
2022
Q4 		$4.8M Buy
70,936
+6,994
+11% +$410K 0.02% 442
2022
Q3 		$3.19M Buy
63,942
+14,374
+29% +$770K 0.02% 531
2022
Q2 		$2.76M Buy
49,568
+6,246
+14% +$347K 0.02% 521
2022
Q1 		$2.43M Buy
43,322
+5,858
+16% +$301K 0.02% 550
2021
Q4 		$2.1M Buy
37,464
+12,000
+47% +$650K 0.01% 554
2021
Q3 		$1.22M Buy
25,464
+274
+1% +$13.2K 0.01% 670
2021
Q2 		$1.05M Buy
25,190
+1,532
+6% +$59.4K 0.01% 701
2021
Q1 		$808K Buy
23,658
+1,628
+7% +$58K 0.01% 778
2020
Q4 		$769K Sell
22,030
-4,300
-16% -$149K 0.01% 690
2020
Q3 		$912K Buy
26,330
+3,126
+13% +$104K 0.02% 539
2020
Q2 		$762K Buy
23,204
+5,912
+34% +$189K 0.01% 575
2020
Q1 		$523K Buy
17,292
+266
+2% +$7.92K 0.01% 582
2019
Q4 		$497K Buy
+17,026
New +$471K 0.01% 688

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

CAPTRUST Financial Advisors's NVO Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its Novo Nordisk (NVO) stake by 20% in Q1 2026, buying an estimated $1.11M and bringing the position to 143,005 shares worth $5.25M. The position accounts for 0.01% of the portfolio, ranked #746.

CAPTRUST Financial Advisors first reported a position in NVO in Q4 2019 and has held it in 26 quarters since. The position peaked at $23M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • CAPTRUST Financial Advisors held 143,005 shares of Novo Nordisk worth $5.25M as of Q1 2026.
  • CAPTRUST Financial Advisors bought 23,442 Novo Nordisk shares in Q1 2026, an estimated $1.11M.
  • Novo Nordisk made up 0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #746 holding.
  • CAPTRUST Financial Advisors first reported a position in Novo Nordisk in Q4 2019 and has held it in 26 quarters since.
  • CAPTRUST Financial Advisors's Novo Nordisk position peaked at $23M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.